Search

everythinglearnresearchcommunity

for

Search:↓

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The document is a detailed medical reference on skin and genetic disorders.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

ADAM17 could be a potential target for treating PCOS.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

The circadian clock affects skin stem cell behavior, impacting aging and cancer risk.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Some medicinal plants can help heal wounds and may lead to new treatments.

Epidermal stem cells are diverse and vary in activity, playing key roles in skin maintenance and repair.

Estrogen therapy can reduce skin aging but has cancer risks.